<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04752852</url>
  </required_header>
  <id_info>
    <org_study_id>233/HFH12/14</org_study_id>
    <nct_id>NCT04752852</nct_id>
  </id_info>
  <brief_title>Use of Prophylactic Steroids in the Prevention of Post-thyroidectomy Hypocalcaemia and Voice Dysfunction</brief_title>
  <official_title>Randomised Control Trial on the Use of Prophylactic Steroids in the Prevention of Post-thyroidectomy Hypocalcaemia and Voice Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Holy Family Hospital, Pakistan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Holy Family Hospital, Pakistan</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total thyroidectomy for benign surgical pathologies is associated with risks related to&#xD;
      temporary hypocalcaemia and vocal quality dysfunction. Dexamethasone, as an anti-inflammatory&#xD;
      steroid, has been proposed to have a physiological effect on hypocalcaemia and voice quality.&#xD;
      Investigators conducted a double-blinded controlled trial to assess the effect of&#xD;
      preoperative dexamethasone on the vocal dysfunction and hypocalcaemia following thyroidectomy&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Actual">July 2020</completion_date>
  <primary_completion_date type="Actual">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hypocalcaemia</measure>
    <time_frame>3 days</time_frame>
    <description>Hypocalcaemia was defined as a corrected serum calcium level of less than 2 mmol/L.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Voice dysfunction</measure>
    <time_frame>24 hours</time_frame>
    <description>Signs and symptoms of voice dysfunction at 24 hours after thyroidectomy. Voice dysfunction was defined on voice analogue score from 0-100. Participants with Voice Analogue Score of less than 50 were labelled as having voice dysfunction, and participants with score more than 50 were considered as normal.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">192</enrollment>
  <condition>Thyroid Diseases</condition>
  <condition>Hypocalcemia</condition>
  <condition>Vocal Cord Dysfunction</condition>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with odd numbers were assigned to group A. 8 mg/2 ml dexamethasone was injected intravenously sixty minutes before the induction of anaesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients with even numbers were assigned to group B. Two millilitres (ml) normal saline (0.9%) was given intravenously 60 minutes before the induction of anaesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>8 mg/2 ml dexamethasone IV, 60 minutes before the induction of anaesthesia</description>
    <arm_group_label>Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>2 ml normal saline (0.9%) IV, 60 minutes before the induction of anaesthesia</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>normal saline (0.9%)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Benign thyroid condition.&#xD;
&#xD;
          -  Patients without any preoperative corrected hypocalcaemia and voice or vocal quality&#xD;
             dysfunction.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous thyroid or neck surgery&#xD;
&#xD;
          -  Known vocal cord dysfunction on laryngoscopy&#xD;
&#xD;
          -  Hearing or voice problems&#xD;
&#xD;
          -  History of gastroesophageal reflux and stomach ulcer disease&#xD;
&#xD;
          -  Contraindications of steroids&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raheel Ahmad, FCPS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Holy Family Hospital Rawalpindi Pakistan</affiliation>
  </overall_official>
  <reference>
    <citation>Worni M, Schudel HH, Seifert E, Inglin R, Hagemann M, Vorburger SA, Candinas D. Randomized controlled trial on single dose steroid before thyroidectomy for benign disease to improve postoperative nausea, pain, and vocal function. Ann Surg. 2008 Dec;248(6):1060-6. doi: 10.1097/SLA.0b013e31818c709a.</citation>
    <PMID>19092351</PMID>
  </reference>
  <reference>
    <citation>Kolahdouzan M, Iraj B, Eslamian M, Harandizadeh M, Meamar R. Preventive Effect of Dexamethasone Therapy on the Transient Hypoparathyroidism through Total Thyroidectomy. Iran J Otorhinolaryngol. 2019 Mar;31(103):73-80.</citation>
    <PMID>30989072</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 8, 2021</study_first_submitted>
  <study_first_submitted_qc>February 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2021</study_first_posted>
  <last_update_submitted>February 11, 2021</last_update_submitted>
  <last_update_submitted_qc>February 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Holy Family Hospital, Pakistan</investigator_affiliation>
    <investigator_full_name>Raheel Ahmad</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Thyroidectomy</keyword>
  <keyword>Postoperative Hypocalcaemia</keyword>
  <keyword>Postoperative Vocal cord dysfunction</keyword>
  <keyword>Dexamethasone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vocal Cord Dysfunction</mesh_term>
    <mesh_term>Hypocalcemia</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

